학술논문
AMG 176, a selective MCL1 inhibitor, is effective in hematologic cancer models alone and in combination with established therapies
Document Type
Article
Author
Caenepeel, S.; Belmontes, B.; Moody, G.; Cajulis, E.; Osgood, T.; Sun, J.; Beltran, P.; Canon, J.; Coxon, A.; Hughes, P.E.; Brown, S.P.; Chui, D.; Poppe, L.; Keegan, K.S.; Whittington, D.A.; Huang, X.; Houze, J.; Cheng, A.C.; Cardozo, M.; Li, Y.; Lucas, B.; Paras, N.A.; Wang, X.; Taygerly, J.P.; Vimolratana, M.; Zancanella, M.; Zhu, L.; Damon, L.; Egan, R.K.; Greninger, P.; McClanaghan, J.D.; Benes, C.H.; Gong, J.; Roberts, A.W.; Huang, D.C.; Moujalled, D.; Pomilio, G.; Wei, A.
Source
In: Cancer Discovery . (Cancer Discovery, December 2018, 8(12):1582-1597)
Subject
Language
English
ISSN
21598290
21598274
21598274